Free Trial

This company has been marked as potentially delisted and may not be actively trading.

resTORbio (TORC) Competitors

resTORbio logo

TORC vs. WHWK, VHAQ, PYRGF, OSTX, AADI, NBRV, ATNM, ELYM, HILS, and EGRX

Should you be buying resTORbio stock or one of its competitors? The main competitors of resTORbio include Whitehawk Therapeutics (WHWK), Viveon Health Acquisition (VHAQ), PyroGenesis Canada (PYRGF), OS Therapies (OSTX), Aadi Bioscience (AADI), Nabriva Therapeutics (NBRV), Actinium Pharmaceuticals (ATNM), Eliem Therapeutics (ELYM), Hillstream BioPharma (HILS), and Eagle Pharmaceuticals (EGRX).

resTORbio vs. Its Competitors

Whitehawk Therapeutics (NASDAQ:WHWK) and resTORbio (NASDAQ:TORC) are both small-cap pharmaceutical preparations industry companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, institutional ownership, profitability, media sentiment and earnings.

Whitehawk Therapeutics has a net margin of 99.42% compared to resTORbio's net margin of 0.00%. Whitehawk Therapeutics' return on equity of -56.73% beat resTORbio's return on equity.

Company Net Margins Return on Equity Return on Assets
Whitehawk Therapeutics99.42% -56.73% -48.68%
resTORbio N/A -78.12%-71.63%

Whitehawk Therapeutics has a beta of 0.55, indicating that its share price is 45% less volatile than the S&P 500. Comparatively, resTORbio has a beta of 2.43, indicating that its share price is 143% more volatile than the S&P 500.

In the previous week, Whitehawk Therapeutics' average media sentiment score of 0.00 equaled resTORbio'saverage media sentiment score.

Company Overall Sentiment
Whitehawk Therapeutics Neutral
resTORbio Neutral

Whitehawk Therapeutics has higher revenue and earnings than resTORbio. resTORbio is trading at a lower price-to-earnings ratio than Whitehawk Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Whitehawk Therapeutics$25.98M3.59-$63.69M$0.1612.38
resTORbioN/AN/A-$82.74M-$2.41-0.25

52.1% of Whitehawk Therapeutics shares are owned by institutional investors. Comparatively, 46.2% of resTORbio shares are owned by institutional investors. 49.9% of Whitehawk Therapeutics shares are owned by insiders. Comparatively, 11.8% of resTORbio shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Whitehawk Therapeutics beats resTORbio on 8 of the 9 factors compared between the two stocks.

Get resTORbio News Delivered to You Automatically

Sign up to receive the latest news and ratings for TORC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TORC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TORC vs. The Competition

MetricresTORbioPharmaceutical Preparations IndustryMedical SectorNASDAQ Exchange
Market Cap$22.13M$784.80M$5.53B$9.03B
Dividend YieldN/A4.84%5.24%4.01%
P/E Ratio-0.341.0919.3119.89
Price / SalesN/A230.50424.59117.07
Price / CashN/A23.4426.2128.59
Price / Book0.276.237.925.55
Net Income-$82.74M-$27.94M$3.17B$248.49M

resTORbio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TORC
resTORbio
N/A$0.61
-1.1%
N/A-43.3%$22.13MN/A-0.34N/A
WHWK
Whitehawk Therapeutics
N/A$1.86
-0.5%
N/AN/A$88.09M$25.98M0.0040
VHAQ
Viveon Health Acquisition
N/A$11.00
flat
N/AN/A$62.26MN/A0.002High Trading Volume
PYRGF
PyroGenesis Canada
0.0919 of 5 stars
$0.33
+0.9%
N/A-41.0%$62.17M$9.14M-5.5590
OSTX
OS Therapies
2.8073 of 5 stars
$1.93
+2.7%
$18.00
+832.6%
N/A$54.23MN/A-2.24N/A
AADI
Aadi Bioscience
0.6423 of 5 stars
$1.87
-3.1%
$1.67
-10.9%
+49.6%$46.18M$25.07M-0.8240
NBRV
Nabriva Therapeutics
N/AN/AN/AN/A$45.46M$35.59M0.0070
ATNM
Actinium Pharmaceuticals
2.7938 of 5 stars
$1.35
-3.6%
$4.00
+196.3%
N/A$42.12M$81K-0.9730Positive News
ELYM
Eliem Therapeutics
N/A$1.24
+5.1%
N/A-80.7%$36.89MN/A-2.349
HILS
Hillstream BioPharma
N/A$1.80
+2.4%
N/A-45.3%$31.73MN/A-2.501
EGRX
Eagle Pharmaceuticals
N/A$2.36
-18.6%
N/A-45.5%$30.65M$257.55M0.00100Gap Down

Related Companies and Tools


This page (NASDAQ:TORC) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners